MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-11-0011686
Wilber Pharmaceutical Private Limited
Wilber Pharmaceutical Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹25.06 Lakh
▼ 29% YoY
Net profit · FY 2025
₹97,138
Net margin 3.9%
EBITDA · FY 2025
₹1.41 Lakh
EBITDA margin 5.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹6 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
Active GSTINs
2
GST registered
About Wilber Pharmaceutical Private Limited
Data last updated:
Wilber Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 11 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85300DL2021PTC378299. Its GSTIN is 07AACCW9046K1ZV (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors Syed Mohammad Rafi and Farheen Jamal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at L – 12 Shyam Park Nawada Uttam Nagar, Delhi, India – 110059.
As per the financials filed for FY 2025, the company reported a revenue of ₹25.06 Lakh, a decline of 29% compared to the previous year. For the same year it recorded a net profit of ₹97,138 (net margin 3.9%) and EBITDA of ₹1.41 Lakh (EBITDA margin 5.6%). Revenue has grown at a compounded annual rate (CAGR) of 52% over three years.
Wilber Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0011686).
Company details
CIN U85300DL2021PTC378299
Registration Number 378299
Incorporation Date 11 March 2021
ROC Delhi
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-DL-11-0011686
Recognitions & Rankings of Wilber Pharmaceutical
Contact details
Wilber Pharmaceutical Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressL – 12 Shyam Park Nawada Uttam Nagar, Delhi, India – 110059
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Wilber Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Wilber Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Wilber Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Wilber Pharmaceutical Private Limited, buy the company report.
Financials of Wilber Pharmaceutical Private Limited
FY 2025 filings availableWilber Pharmaceutical Private Limited reported revenue of ₹25.06 Lakh (down 29% YoY) for FY 2025.
Revenue · FY 2025
₹25.06 Lakh ▼ 29%
Net profit · FY 2025
₹97,138 margin 3.9%
EBITDA · FY 2025
₹1.41 Lakh margin 5.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 29%
3 years · compounded
▲ 52%
EBITDA CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 64%
Revenue fell 29% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 52%. EBITDA rose 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.41 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹97,138 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.6% | ||||
| Net Profit Margin | 3.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Wilber Pharmaceutical Private Limited, buy the company report.
Board of directors of Wilber Pharmaceutical Private Limited
Wilber Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Syed Mohammad Rafi | Director | 11 Mar 2021 | 5 Years 8 Months | Current |
| Farheen Jamal | Director | 28 Jul 2021 | 5 Years 3 Months | Current |
Peer comparison
Wilber Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shasari Healthcare India Private Limited | ₹25.71 Lakh (FY 2025) | Noida, Uttar Pradesh, India | ||||
| Medisson Healthcare Solutions Private Limited | ₹25.53 Lakh (FY 2025) | -51.0% | Vaishali Nagar, Jaipur, Rajasthan, India | |||
| Vedmed Care Private Limited | ₹25.53 Lakh (FY 2025) | New Delhi, Delhi, India | ||||
| Smilemax Hygiene Private Limited | ₹25.4 Lakh (FY 2025) | 589.0% | Jaipur, Rajasthan, India | |||
| Eldorex Pharmaceuticals Private Limited | ₹25.2 Lakh (FY 2025) | 149.0% | Thane, Maharashtra, India | |||
| Wilber Pharmaceutical Private Limitedthis company | ₹25.06 Lakh (FY 2025) | ₹97,138 | 3.9% | -29.0% | Delhi, India | |
| Adigen Biogenesis Private Limited | ₹24.94 Lakh (FY 2025) | 352.0% | Kolkata, West Bengal, India | |||
| Derm Quest Private Limited | ₹24.67 Lakh (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Wondamed Pharmaceuticals Private Limited | ₹24.57 Lakh (FY 2025) | 16.0% | Jaipur, Rajasthan, India | |||
| Amezia Pharmaceutical Private Limited | ₹24.54 Lakh (FY 2025) | 75.0% | Mumbai, Maharashtra, India | |||
| Merit Healthcare Private Limited | ₹24.51 Lakh (FY 2025) | -32.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Wilber Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Wilber Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Wilber Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Wilber Pharmaceutical has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AACCW9046K1ZV | Delhi | Active | 25 Mar 2021 |
| 10AACCW9046K1Z8 | Bihar | Active | 17 Dec 2021 |
To see the full GST registrations and return filing status of Wilber Pharmaceutical Private Limited, buy the company report.
Recent activity
Wilber Pharmaceutical Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Syed Manzoor Hussain ceased to be Director on 29 Jul 2021.
AGM
Wilber Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Wilber Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Ceased
Syed Manzoor Hussain ceased to be Director.
Appointed
Farheen Jamal was appointed as Director.
Appointed
Syed Mohammad Rafi was appointed as Director.
Incorporation
11 Mar 2021
Wilber Pharmaceutical Private Limited was registered on 11 Mar 2021 with Roc Delhi Ii & aged 5 years 8 months as per MCA records.
Frequently asked questions
Wilber Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 11 March 2021 (5+ years old) and is registered under CIN U85300DL2021PTC378299.
Wilber Pharmaceutical has 2 current directors:
- Syed Mohammad Rafi - Director
- Farheen Jamal - Director
The latest financial statements of Wilber Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Wilber Pharmaceutical is 07AACCW9046K1ZV, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 10AACCW9046K1Z8 (Bihar).
The CIN (Corporate Identification Number) of Wilber Pharmaceutical is U85300DL2021PTC378299. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wilber Pharmaceutical was incorporated on 11 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Wilber Pharmaceutical by revenue are Shasari Healthcare India Private Limited, Medisson Healthcare Solutions Private Limited, Vedmed Care Private Limited, Smilemax Hygiene Private Limited, Eldorex Pharmaceuticals Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Syed Manzoor Hussain ceased to be Director on 29 Jul 2021. Farheen Jamal was appointed as Director on 28 Jul 2021. Syed Mohammad Rafi was appointed as Director on 11 Mar 2021.
Yes, Wilber Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0011686).
The registered office of Wilber Pharmaceutical is at L – 12 Shyam Park Nawada Uttam Nagar, Delhi, India – 110059.
Wilber Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages